Case Report: Clinical response of ensartinib for inflammatory myofibroblastic tumor of the urinary bladder with multiple metastases and TPM4-ALK fusion

Case Report: Clinical response of ensartinib for inflammatory myofibroblastic tumor of the urinary bladder with multiple metastases and TPM4-ALK fusion

BackgroundInflammatory myofibroblastic tumor of the urinary bladder (IMTUB) is a rare tumor with low postoperative recurrence and metastasis. Due to the lack of clinical evidence, the optimal treatment paradigm for patients with IMTUB has not yet been established.Case presentationWe reported a case...

Full description

Saved in:
Bibliographic Details
Main Authors: Hongtao Ren, Qi Cheng, Xi Chen, Dianjing Sui, Zhiyi Zhang, Fei Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Oncology
Subjects:
ensartinib
inflammatory myofibroblastic tumor
urinary bladder
multiple metastases
TPM4-ALK
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1481602/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items